# Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women

> **NCT06285799** · PHASE3 · COMPLETED · sponsor: **Nemysis Ltd** · enrollment: 180 (actual)

## Conditions studied

- Iron-deficiency

## Interventions

- **DRUG:** Low Dose IHAT
- **DRUG:** High Dose IHAT
- **DRUG:** Carob Flour

## Key facts

- **NCT ID:** NCT06285799
- **Lead sponsor:** Nemysis Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-05
- **Primary completion:** 2025-02-11
- **Final completion:** 2025-02-15
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2025-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06285799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06285799, "Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06285799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*